Loading stock data…
BGLC
$2.08-0.02 (-1.01%)
Market ClosedLast close May 1
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
BioNexus Gene Lab Corp. in the Basic Materials sector is trading at $2.08. The stock is currently near its 52-week low of $1.92, remaining 48.7% below its 200-day moving average. Technical signals show neutral RSI of 31 and bearish MACD signal, explaining why BGLC maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 31) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.08
Potential Upside
5%
Whystock Fair Value$2.18
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other c...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.48M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.31
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.61%
Volume
Today's trading volume
3,073
Recent News
Top Midday Gainers
XBP Europe (XBP) said Wednesday it finalized its acquisition of Exela Technologies BPA, a business p
Wall Street Set to Open Lower Wednesday as Jobs Data Misses Forecasts
US stocks look set to open lower in Wednesday's trading session as key employment data missed analys
US Futures Subdued as Investors Eye Key Employment Data
US stock futures were subdued premarket Wednesday as investors eyed key employment figures this morn